Evidence check: ADH1B in the context of menopause

ADH1B encodes alcohol dehydrogenase and influences alcohol metabolism rate. During menopause, hormonal changes may theoretically alter alcohol tolerance and health risks (e.g., breast cancer, bone density). However, the provided context does not include specific studies linking ADH1B to menopause. The evidence for a direct, clinically relevant association is moderate to unclear. A genetic test for ADH1B can provide insight into individual alcohol sensitivity but should not be the sole basis for menopause-related decisions. MyBody-X does not offer a specific ADH1B test in the menopause context. The predictive value is limited, as lifestyle, diet, and hormone status are more influential.